Cargando…
Metformin potentiates nephrotoxicity by promoting NETosis in response to renal ferroptosis
Given the rapidly aging population, aging-related diseases are becoming an excessive burden on the global healthcare system. Metformin has been shown to be beneficial to many age-related disorders, as well as increase lifespan in preclinical animal models. During the aging process, kidney function p...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582023/ https://www.ncbi.nlm.nih.gov/pubmed/37848438 http://dx.doi.org/10.1038/s41421-023-00595-3 |
_version_ | 1785122237087481856 |
---|---|
author | Cai, Zhaoxian Wu, Xiaotian Song, Zijun Sun, Shumin Su, Yunxing Wang, Tianyi Cheng, Xihao Yu, Yingying Yu, Chao Chen, En Chen, Wenteng Yu, Yongping Linkermann, Andreas Min, Junxia Wang, Fudi |
author_facet | Cai, Zhaoxian Wu, Xiaotian Song, Zijun Sun, Shumin Su, Yunxing Wang, Tianyi Cheng, Xihao Yu, Yingying Yu, Chao Chen, En Chen, Wenteng Yu, Yongping Linkermann, Andreas Min, Junxia Wang, Fudi |
author_sort | Cai, Zhaoxian |
collection | PubMed |
description | Given the rapidly aging population, aging-related diseases are becoming an excessive burden on the global healthcare system. Metformin has been shown to be beneficial to many age-related disorders, as well as increase lifespan in preclinical animal models. During the aging process, kidney function progressively declines. Currently, whether and how metformin protects the kidney remains unclear. In this study, among longevity drugs, including metformin, nicotinamide, resveratrol, rapamycin, and senolytics, we unexpectedly found that metformin, even at low doses, exacerbated experimentally-induced acute kidney injury (AKI) and increased mortality in mice. By single-cell transcriptomics analysis, we found that death of renal parenchymal cells together with an expansion of neutrophils occurs upon metformin treatment after AKI. We identified programmed cell death by ferroptosis in renal parenchymal cells and blocking ferroptosis, or depleting neutrophils protects against metformin-induced nephrotoxicity. Mechanistically, upon induction of AKI, ferroptosis in renal parenchymal cells initiates the migration of neutrophils to the site of injury via the surface receptor CXCR4–bound to metformin–iron–NGAL complex, which results in NETosis aggravated AKI. Finally, we demonstrated that reducing iron showed protective effects on kidney injury, which supports the notion that iron plays an important role in metformin-triggered AKI. Taken together, these findings delineate a novel mechanism underlying metformin-aggravated nephropathy and highlight the mechanistic relationship between iron, ferroptosis, and NETosis in the resulting AKI. |
format | Online Article Text |
id | pubmed-10582023 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Nature Singapore |
record_format | MEDLINE/PubMed |
spelling | pubmed-105820232023-10-19 Metformin potentiates nephrotoxicity by promoting NETosis in response to renal ferroptosis Cai, Zhaoxian Wu, Xiaotian Song, Zijun Sun, Shumin Su, Yunxing Wang, Tianyi Cheng, Xihao Yu, Yingying Yu, Chao Chen, En Chen, Wenteng Yu, Yongping Linkermann, Andreas Min, Junxia Wang, Fudi Cell Discov Article Given the rapidly aging population, aging-related diseases are becoming an excessive burden on the global healthcare system. Metformin has been shown to be beneficial to many age-related disorders, as well as increase lifespan in preclinical animal models. During the aging process, kidney function progressively declines. Currently, whether and how metformin protects the kidney remains unclear. In this study, among longevity drugs, including metformin, nicotinamide, resveratrol, rapamycin, and senolytics, we unexpectedly found that metformin, even at low doses, exacerbated experimentally-induced acute kidney injury (AKI) and increased mortality in mice. By single-cell transcriptomics analysis, we found that death of renal parenchymal cells together with an expansion of neutrophils occurs upon metformin treatment after AKI. We identified programmed cell death by ferroptosis in renal parenchymal cells and blocking ferroptosis, or depleting neutrophils protects against metformin-induced nephrotoxicity. Mechanistically, upon induction of AKI, ferroptosis in renal parenchymal cells initiates the migration of neutrophils to the site of injury via the surface receptor CXCR4–bound to metformin–iron–NGAL complex, which results in NETosis aggravated AKI. Finally, we demonstrated that reducing iron showed protective effects on kidney injury, which supports the notion that iron plays an important role in metformin-triggered AKI. Taken together, these findings delineate a novel mechanism underlying metformin-aggravated nephropathy and highlight the mechanistic relationship between iron, ferroptosis, and NETosis in the resulting AKI. Springer Nature Singapore 2023-10-17 /pmc/articles/PMC10582023/ /pubmed/37848438 http://dx.doi.org/10.1038/s41421-023-00595-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Cai, Zhaoxian Wu, Xiaotian Song, Zijun Sun, Shumin Su, Yunxing Wang, Tianyi Cheng, Xihao Yu, Yingying Yu, Chao Chen, En Chen, Wenteng Yu, Yongping Linkermann, Andreas Min, Junxia Wang, Fudi Metformin potentiates nephrotoxicity by promoting NETosis in response to renal ferroptosis |
title | Metformin potentiates nephrotoxicity by promoting NETosis in response to renal ferroptosis |
title_full | Metformin potentiates nephrotoxicity by promoting NETosis in response to renal ferroptosis |
title_fullStr | Metformin potentiates nephrotoxicity by promoting NETosis in response to renal ferroptosis |
title_full_unstemmed | Metformin potentiates nephrotoxicity by promoting NETosis in response to renal ferroptosis |
title_short | Metformin potentiates nephrotoxicity by promoting NETosis in response to renal ferroptosis |
title_sort | metformin potentiates nephrotoxicity by promoting netosis in response to renal ferroptosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582023/ https://www.ncbi.nlm.nih.gov/pubmed/37848438 http://dx.doi.org/10.1038/s41421-023-00595-3 |
work_keys_str_mv | AT caizhaoxian metforminpotentiatesnephrotoxicitybypromotingnetosisinresponsetorenalferroptosis AT wuxiaotian metforminpotentiatesnephrotoxicitybypromotingnetosisinresponsetorenalferroptosis AT songzijun metforminpotentiatesnephrotoxicitybypromotingnetosisinresponsetorenalferroptosis AT sunshumin metforminpotentiatesnephrotoxicitybypromotingnetosisinresponsetorenalferroptosis AT suyunxing metforminpotentiatesnephrotoxicitybypromotingnetosisinresponsetorenalferroptosis AT wangtianyi metforminpotentiatesnephrotoxicitybypromotingnetosisinresponsetorenalferroptosis AT chengxihao metforminpotentiatesnephrotoxicitybypromotingnetosisinresponsetorenalferroptosis AT yuyingying metforminpotentiatesnephrotoxicitybypromotingnetosisinresponsetorenalferroptosis AT yuchao metforminpotentiatesnephrotoxicitybypromotingnetosisinresponsetorenalferroptosis AT chenen metforminpotentiatesnephrotoxicitybypromotingnetosisinresponsetorenalferroptosis AT chenwenteng metforminpotentiatesnephrotoxicitybypromotingnetosisinresponsetorenalferroptosis AT yuyongping metforminpotentiatesnephrotoxicitybypromotingnetosisinresponsetorenalferroptosis AT linkermannandreas metforminpotentiatesnephrotoxicitybypromotingnetosisinresponsetorenalferroptosis AT minjunxia metforminpotentiatesnephrotoxicitybypromotingnetosisinresponsetorenalferroptosis AT wangfudi metforminpotentiatesnephrotoxicitybypromotingnetosisinresponsetorenalferroptosis |